Predict your next investment

Corporation
HEALTHCARE | Medical Equipment & Supplies
biopure.com

See what CB Insights has to offer

Founded Year

1984

Stage

Dead | Dead

Total Raised

$107.13M

About Biopure Corporation

Biopure's product is a "blood substitute," or more properly defined as a hemoglobin- based oxygen carrier (HBOCs). The hemoglobin is derived from a bovine source. The product is universally compatible, requiring no blood-typing or cross-matching, and virtually eliminates the risk of transmission of diseases such as AIDS or hepatitis. Biopure has two major products: Hemopure for human use and Oxyglobin for veterinary use.

Biopure Corporation Headquarter Location

11 Hurley Street

Cambridge, Massachusetts, 02141,

United States

617-234-6500

Latest Biopure Corporation News

Watson-Marlow announces details of the new U.S. manufacturing facility

Nov 15, 2021

Watson-Marlow is pleased to announce that construction began in October 2021, on a new state-of-the-art manufacturing facility in the United States, with first production due in late 2022. Following an announcement made earlier this year, the Company is pleased to provide further details about the new facility which will be dedicated to its range of industry leading products, including peristaltic pumps, tubing, fluid path solutions and BioPure components. More Headlines Part of Spirax-Sarco Engineering plc, a FTSE100 Company, Watson-Marlow specializes in high-quality fluid management solutions for the life sciences and process industries. This significant investment in the expansion of its manufacturing capacity will support the Company's future growth in the Americas. Located in Devens, Massachusetts, USA, the 150,000 square foot (14,000 square metres) facility will be close to the life sciences hub in the Cambridge/Boston area. The site will incorporate a suite of eight ISO14644-1 Class 7 cleanrooms, warehousing and offices, with space for two further cleanrooms within the initial footprint. With segregated cleanroom and non-cleanroom production capabilities, Watson-Marlow's new U.S. facility will strengthen the support the Company provides to customers in the region across its core sectors of pharmaceutical and biotechnology, medical diagnostics, and process industries. "The new U.S. facility is an important milestone in the Watson-Marlow company history and marks a significant commitment to serving our customers in the Americas region." Says Andrew Mines, Watson-Marlow Managing Director, "This exciting development is bringing us closer to our customers whose purpose is to help the world around us, from advancing cell and gene therapies through to ensuring people have access to clean drinking water. Together we will continue to develop market-leading fluid management solutions to engineer a more sustainable future. A huge thanks goes to the Watson-Marlow, BioPure, Americas and Watson-Marlow Central Support teams that are making this happen, as well as to our parent Company, Spirax-Sarco Engineering who have enabled us to make such a significant investment in our future." Watson-Marlow is an award-winning employer and this new facility will bring significant job opportunities to the local area, with over 150 positions coming available. Production at the new facility will replicate that of Watson-Marlow's European sites, ensuring continued product quality for customers, by using the same raw materials, components, processes and work instructions. Completion of the facility is due in late 2022, with the first products due to be shipped from the site in late Q4.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Biopure Corporation Patents

Biopure Corporation has filed 4 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/19/2010

8/25/2015

Pharmaceutical industry, Samurai, Medical equipment, Catheters, Endoscopy

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/19/2010

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/25/2015

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Pharmaceutical industry, Samurai, Medical equipment, Catheters, Endoscopy

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.